** Brokerage Jefferies trim price target on Australia's Monash IVF MVF.AX to A$1.25 per share from A$1.45 per share
** Monash on Tuesday, downgraded its FY25 underlying NPAT forecast to about A$27.5 million ($17.69 million), from its previous forecast of A$30.0 million to A$31.0 million
** Believe this is in part due to the somewhat discretionary nature of IVF as well as MVF’s exposure to Victoria, a state that is facing economic challenges - Jefferies
** Six of seven analysts rate the stock "buy" or higher, one "hold"; their median PT is A$1.17, according to data compiled by LSEG
** Stock has fallen 39.4% this year, as of last close
($1 = 1.5545 Australian dollars)
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.